三峽能源(600905.SH):2021年度投產裝機容量合計2289.6萬千瓦 同比增長47%
格隆匯3月10日丨三峽能源(600905.SH)公佈2021年度新增裝機容量公吿,據統計,中國三峽新能源(集團)股份有限公司2021年度新增裝機容量合計728萬千瓦(已扣除因轉讓等原因減少2萬千瓦),其中,風電裝機539萬千瓦,太陽能發電裝機190萬千瓦。
截至2021年末,公司投產裝機容量合計2289.6萬千瓦,較2020年末投產裝機容量增長47%。其中,風電裝機1426.9萬千瓦,較2020年末增長61%;太陽能發電裝機841.2萬千瓦,較2020年末增長29%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.